Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

A. Endsley · SciRah

Researcher profile · Semantic Scholar

A. Endsley

Share profile

A. Endsley — researcher profile on SciRah

h-index: 12
Works: 31
Citations: 1,043

Most-cited papers

Design considerations for liposomal vaccines: Influence of formulation parameters on antibody and cell-mediated immune responses to liposome associated antigens
Douglas S. Watson, A. Endsley, Leaf Huang
2012Vaccine316 citations Open access
Semantic Scholar
Evaluation of Ebola Virus Inhibitors for Drug Repurposing.
P. Madrid, R. Panchal, Travis K. Warren, A. Shurtleff +8 more
2015ACS Infectious Diseases246 citations
Semantic Scholar
(+)-SJ733, a clinical candidate for malaria that acts through ATP4 to induce rapid host-mediated clearance of Plasmodium
M. Jiménez-Díaz, D. Ebert, Yandira G. Salinas, Anupam Pradhan +46 more
2014Proceedings of the National Academy of Sciences of the United States of America239 citations Open access
Semantic Scholar
Enhanced anti-HIV efficacy of Indinavir after inclusion in CD4 targeted lipid nanoparticles
A. Endsley, R. Ho
2012Journal of Acquired Immune Deficiency Syndromes44 citations Open access
Semantic Scholar
Design and Characterization of Novel Peptide-Coated Lipid Nanoparticles for Targeting Anti-HIV Drug to CD4 Expressing Cells
A. Endsley, R. Ho
2012AAPS Journal27 citations Open access
Semantic Scholar
First in Human Evaluation and Dosimetry Calculations for Peptide 124I-p5+14—a Novel Radiotracer for the Detection of Systemic Amyloidosis Using PET/CT Imaging
J. Wall, E. Martin, A. Endsley, A. Stuckey +9 more
2021Molecular Imaging and Biology23 citations
Semantic Scholar
Biodistribution of the Multidentate Hydroxypyridinonate Ligand [14C]‐3,4,3‐LI(1,2‐HOPO), a Potent Actinide Decorporation Agent
Taylor A. Choi, A. Endsley, Deborah I. Bunin, C. Colas +7 more
2015Drug development research (Print)20 citations
Semantic Scholar
Comparative analysis of the substrate preferences of two post-proline cleaving endopeptidases, prolyl oligopeptidase and fibroblast activation protein α
Kalyani Jambunathan, Douglas S. Watson, A. Endsley, K. Kodukula +1 more
2012FEBS Letters19 citations Open access
Semantic Scholar
POS-109 INTERIM RESULTS OF PHASE 1 AND 2 TRIALS TO INVESTIGATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, PHARMACODYNAMICS, AND CLINICAL ACTIVITY OF BION-1301 IN PATIENTS WITH IgA NEPHROPATHY
J. Barratt, B. Hour, L. Kooienga, S. Roy +8 more
2022Kidney International Reports15 citations Open access
Semantic Scholar
Correction for Jiménez-Díaz et al., (+)-SJ733, a clinical candidate for malaria that acts through ATP4 to induce rapid host-mediated clearance of Plasmodium
M. Jiménez-Díaz, D. Ebert, Yandira G. Salinas, Anupam Pradhan +46 more
2015Proceedings of the National Academy of Sciences of the United States of America15 citations Open access
Semantic Scholar
β-Carotene Biosynthesis in Probiotic Bacteria
Jennifer K. Miller, M. T. Harrison, A. D'Andrea, A. Endsley +3 more
2013Probiotics and Antimicrobial Proteins15 citations
Semantic Scholar
Corrigendum to "Design considerations for liposomal vaccines: Influence of formulation parameters on antibody and cell-mediated immune responses to liposome associated antigens" [Vaccine 30 (13) (2012) 2256-2272]
Douglas S. Watson, A. Endsley, Leaf Huang
201213 citations Open access
Semantic Scholar
FC 040INTERIM RESULTS OF PHASE 1 AND 2 TRIALS TO INVESTIGATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, PHARMACODYNAMICS, AND CLINICAL ACTIVITY OF BION-1301 IN PATIENTS WITH IGA NEPHROPATHY
Jonathan Barratt, B. Hour, C. Sibley, A. Mittan +5 more
20219 citations
Semantic Scholar
MO212: Updated Interim Results of A Phase 1/2 Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Clinical Activity of BION-1301 in Patients With IGA Nephropathy
Jonathan Barratt, L. Kooienga, B. Hour, I. Agha +8 more
2022Nephrology, Dialysis and Transplantation8 citations
Semantic Scholar
Utilizing native fluorescence imaging, modeling and simulation to examine pharmacokinetics and therapeutic regimen of a novel anticancer prodrug
Jing-Hung Wang, A. Endsley, C. Green, A. Matin
2016BMC Cancer7 citations Open access
Semantic Scholar
Site‐specific Substitutions Eliminate Aggregation Properties of Hemopressin
Ben-Ben Song, Patrick Kibler, A. Endsley, S. Nayak +2 more
2015Chemical Biology and Drug Design7 citations
Semantic Scholar
Recent developments in drug targets and delivery of anti-HIV drugs.
N. Salama, A. Endsley, R. Ho
2006Infectious Diseases - Drug Targets5 citations
Semantic Scholar
Pharmacodynamic and Clinical Responses to BION-1301 in Patients with IgA Nephropathy: Initial Results of a Ph1/2 Trial
Jonathan Barratt, Billy T. Hour, Brian S. Schwartz, Bess Sorensen +7 more
2021Journal of the American Society of Nephrology4 citations
Semantic Scholar
Combining drug and immune therapy: a potential solution to drug resistance and challenges of HIV vaccines?
A. Endsley, N. Salama, R. Ho
2008Current HIV Research4 citations
Semantic Scholar
Evaluation of dimethandrolone undecanoate in non‐human primates as a candidate for long‐acting injectable male contraceptive
Deborah I. Bunin, Kyuri Kim, Toufan Parman, Janet Gahagen +8 more
2024Andrology3 citations Open access
Semantic Scholar
P0500RESULTS OF A PHASE 1 TRIAL TO INVESTIGATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND PHARMACODYNAMICS OF BION-1301 IN HEALTHY VOLUNTEERS
Jeannette Lo, P. van Zandvoort, J. M. van de Crommert, A. Endsley +6 more
20202 citations
Semantic Scholar
P0379BION-1301, A FULLY BLOCKING ANTIBODY TARGETING APRIL FOR THE TREATMENT OF IGA NEPHROPATHY: ASSESSMENT OF SAFETY, PHARMACOKINETICS AND PHARMACODYNAMICS IN LONG-TERM NONCLINICAL STUDIES
J. Kreijtz, P. van Zandvoort, J. van de Crommert, M. Friesen +5 more
20201 citations Open access
Semantic Scholar
Results of a Phase 1 Trial to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BION-1301 in Healthy Volunteers
Jeannette Lo, Sharon Yavrom, Jessy Fan, A. Endsley +3 more
2020Journal of the American Society of Nephrology1 citations
Semantic Scholar
Elucidation of the time course of adenosine deaminase APOBEC3G and viral infectivity factor vif in HIV-2287-infected infant macaques
A. Endsley, R. Ho
2011Journal of medical primatology1 citations Open access
Semantic Scholar
3094-LB: FBL-140, a Best-in-Class ActR2A/B mAb Designed for Infrequent SC Dosing for Treatment of Obesity
V. Sood, Shun He, David J. Baker, R. Wideman +6 more
2026Diabetes0 citations
Semantic Scholar
MO286DESIGN OF A PH1, MULTICENTER TRIAL TO INVESTIGATE THE SAFETY, TOLERABILITY, PK/PD OF BION-1301 IN HEALTHY VOLUNTEERS AND ADULTS WITH IGAN AND A MULTICENTER, OPEN-LABEL EXTENSION STUDY FOR IGAN PATIENTS WHO PARTICIPATED IN A PRIOR TRIAL OF BION-1301
Jonathan Barratt, A. Mittan, Suzanne E. Roy, C. Sibley +4 more
2021Nephrology, Dialysis and Transplantation0 citations
Semantic Scholar
POS-144 A PHASE 1, OPEN-LABEL, RANDOMIZED, SINGLE-DOSE, PARALLEL GROUP SAFETY AND BIOAVAILABILITY STUDY OF BION-1301 ADMINISTERED BY INTRAVENOUS (IV) AND SUBCUTANEOUS (SC) ROUTES
C. Sibley, A. Mittan, A. Endsley, S. Roy +4 more
20210 citations Open access
Semantic Scholar
Utilizing native fluorescence imaging, modeling and simulation to examine pharmacokinetics and therapeutic regimen of a novel anticancer prodrug
Jing-Hung Wang, A. Endsley, C. Green, A. Matin
2016BMC Cancer0 citations Open access
Semantic Scholar
Evaluation of functional activity and aggregation properties of hemopressin (1054.2)
S. Nayak, Ben-Ben Song, P. Kibler, Amina S. Adem +3 more
20140 citations
Semantic Scholar
Design and Characterization of Novel Peptide-Coated Lipid Nanoparticles for Targeting Anti-HIV Drug to CD4 Expressing Cells
A. Endsley, R. Ho
2012AAPS Journal0 citations Open access
Semantic Scholar
Advertising in Video Games and Proper Add Placement
Michael Frost, A. Endsley, J. Neal
20100 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

Jonathan Barratt×6
Invite
Jonathan Barratt — researcher profile on SciRah
Jeannette Lo×6
Invite
Jeannette Lo — researcher profile on SciRah
R. Ho×5
Invite
R. Ho — researcher profile on SciRah
A. Glicklich×5
Invite
A. Glicklich — researcher profile on SciRah

Douglas S. Watson

×4

Invite

Douglas S. Watson — researcher profile on SciRah

Invite

A. Mittan — researcher profile on SciRah

Invite

C. Green — researcher profile on SciRah

Kalyani Jambunathan×3

Invite

Kalyani Jambunathan — researcher profile on SciRah

Amit K. Galande×3

Invite

Amit K. Galande — researcher profile on SciRah

Invite

B. Hour — researcher profile on SciRah

Invite

C. Stromatt — researcher profile on SciRah

Suzanne E. Roy×3

Invite

Suzanne E. Roy — researcher profile on SciRah